Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Systematic review

Vol. 149 No. 3536 (2019)

The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review

  • Philipp Kernen
  • Esther H. Steveling-Klein
  • Ramon T. Saccilotto
  • Heike Raatz
  • Matthias Briel
  • Michael T. Koller
  • Marie Westwood
  • Heiner C. Bucher
  • David Miedinger
  • Jörg D. Leuppi
DOI
https://doi.org/10.4414/smw.2019.20100
Cite this as:
Swiss Med Wkly. 2019;149:w20100
Published
02.09.2019

Summary

OBJECTIVE

Asthma is associated with bronchial hyperresponsiveness, assessed by bronchial provocation tests such as the mannitol test. We aimed to assess the data on sensitivity and specificity of the mannitol test in diagnosing asthma.

DATA SOURCES

We searched electronically the Medline, Embase and Central databases from 1997 to 2019.

STUDY SELECTION

Inclusion criteria were the assessment of the validity of the mannitol test. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2). Data were extracted according to a prespecified list and analysed qualitatively.

RESULTS

A total of 27 studies (4589 individuals, age 6–85 years, cross-sectional [n = 18] and case-controlled [n = 9] study design) were included. Overall sensitivity and specificity ranged from 8% (95% confidence interval [CI] 1–27) to 100% (95% CI 93–100) and 75% (95% CI 67–82) to 100% (95% CI 85–100). Excluding case-controlled design, studies conducted in a clinical setting showed a range from 19% (95% CI 14–27) to 91% (95% CI 59–100) for sensitivity and from 75% (95% CI 67–82) to 100% (95% CI 80–100) for specificity. Heterogeneity was high owing to differences in the populations examined and the methods used.

CONCLUSIONS

Studies on the accuracy of the mannitol test were heterogeneous. Overall specificity was higher than sensitivity and therefore the mannitol test seems to be a suitable diagnostic tool to confirm asthma. However, the high level of heterogeneity among the included studies makes a conclusive statement on the accuracy of the mannitol test difficult and further research is needed. As bronchial provocation tests can be especially useful in patients with an intermediate probability of asthma diagnosis, further studies are needed that include subjects with asthma symptoms but intermediate probability of asthma diagnosis.

References

  1. GINA Board. Global Strategy for Asthma management and prevention [Internet]. 2015 [cited 2015 Dec 1]. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2015.pdf
  2. Fanta CH. Diagnosis of asthma in adolescents and adults. UpToDate. 2015. Available from: https://www.uptodate.com/contents/diagnosis-of-asthma-in-adolescents-and-adults.
  3. Leuppi JD, Brannan JD, Anderson SD. Bronchial provocation tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Swiss Med Wkly. 2002;132(13-14):151–8.
  4. Coates AL, Wanger J, Cockcroft DW, Culver BH, Carlsen K-H, Diamant Z, et al., Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526. doi:.https://doi.org/10.1183/13993003.01526-2016
  5. Porsbjerg C, Rasmussen L, Thomsen SF, Brannan JD, Anderson SD, Backer V. Response to mannitol in asymptomatic subjects with airway hyper-responsiveness to methacholine. Clin Exp Allergy. 2007;37(1):22–8. doi:.https://doi.org/10.1111/j.1365-2222.2006.02614.x
  6. Anderson SD. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine, and mannitol. Curr Opin Pulm Med. 2008;14(1):39–45. doi:.https://doi.org/10.1097/MCP.0b013e3282f197f6
  7. Pharmaxis Ltd. Product Information Aridol [Internet]. 2014 [cited 2016 Apr 1]. p. 1–7. Available from: http://www.aridol.info/assets/pdf/20140626_Aridol_PI_AUS.pdf
  8. Miedinger D, Mosimann N, Meier R, Karli C, Florek P, Frey F, et al. Asthma tests in the assessment of military conscripts. Clin Exp Allergy. 2010;40(2):224–31. doi:.https://doi.org/10.1111/j.1365-2222.2009.03387.x
  9. Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Diagnostic properties of inhaled mannitol in the diagnosis of asthma: a population study. J Allergy Clin Immunol. 2009;124(5):928–32.e1. doi:.https://doi.org/10.1016/j.jaci.2009.06.028
  10. Anderson SD, Charlton B, Weiler JM, Nichols S, Spector SL, Pearlman DS ; A305 Study Group. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res. 2009;10(1):4. doi:.https://doi.org/10.1186/1465-9921-10-4
  11. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol. 2008;122(2):238–46, quiz 247–8. doi:.https://doi.org/10.1016/j.jaci.2008.06.014
  12. Miedinger D, Chhajed PN, Tamm M, Stolz D, Surber C, Leuppi JD. Diagnostic tests for asthma in firefighters. Chest. 2007;131(6):1760–7. doi:.https://doi.org/10.1378/chest.06-2218
  13. Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B ; Aridol Study Group. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res. 2005;6(1):144. doi:.https://doi.org/10.1186/1465-9921-6-144
  14. Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al.; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. doi:.https://doi.org/10.7326/0003-4819-155-8-201110180-00009
  15. Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med. 1997;156(3):758–65. doi:.https://doi.org/10.1164/ajrccm.156.3.9701113
  16. Lund TK, Pedersen L, Anderson SD, Sverrild A, Backer V. Are asthma-like symptoms in elite athletes associated with classical features of asthma? Br J Sports Med. 2009;43(14):1131–5. doi:.https://doi.org/10.1136/bjsm.2008.054924
  17. Romberg K, Tufvesson E, Bjermer L. Extended diagnostic criteria used for indirect challenge testing in elite asthmatic swimmers. Respir Med. 2012;106(1):15–24. doi:.https://doi.org/10.1016/j.rmed.2011.09.011
  18. Ulrik CS, Svenningsen C. High prevalence of asthma in Danish elite canoe- and kayak athletes. Dan Med J. 2012;59(4):A4405.
  19. Barben J, Kuehni CE, Strippoli MP, Schiller B, Hammer J, Trachsel D ; Swiss Paediatric Respiratory Research Group. Mannitol dry powder challenge in comparison with exercise testing in children. Pediatr Pulmonol. 2011;46(9):842–8. doi:.https://doi.org/10.1002/ppul.21453
  20. Toennesen LL, Porsbjerg C, Pedersen L, Backer V. Predictors of airway hyperresponsiveness in elite athletes. Med Sci Sports Exerc. 2015;47(5):914–20. doi:.https://doi.org/10.1249/MSS.0000000000000496
  21. Backer V, Sverrild A, Porsbjerg C. FENO and AHR mannitol in patients referred to an out-of-hospital asthma clinic: a real-life study. J Asthma. 2014;51(4):411–6. doi:.https://doi.org/10.3109/02770903.2013.878953
  22. Clearie KL, Williamson PA, Vaidyanathan S, Short P, Goudie A, Burns P, et al. Disconnect between standardized field-based testing and mannitol challenge in Scottish elite swimmers. Clin Exp Allergy. 2010;40(5):731–7. doi:.https://doi.org/10.1111/j.1365-2222.2010.03461.x
  23. Holzer K, Anderson SD, Chan HK, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003;167(4):534–7. doi:.https://doi.org/10.1164/rccm.200208-916OC
  24. Andregnette-Roscigno V, Fernández-Nieto M, Arochena L, García Del Potro M, Aguado E, Sastre J. Methacholine is more sensitive than mannitol for evaluation of bronchial hyper-responsiveness in youth athletes with exercise-induced bronchoconstriction. Pediatr Allergy Immunol. 2012;23(5):501–3. doi:.https://doi.org/10.1111/j.1399-3038.2012.01293.x
  25. Koskela HO, Hyvärinen L, Brannan JD, Chan HK, Anderson SD. Responsiveness to three bronchial provocation tests in patients with asthma. Chest. 2003;124(6):2171–7. doi:.https://doi.org/10.1378/chest.124.6.2171
  26. Subbarao P, Brannan JD, Ho B, Anderson SD, Chan HK, Coates AL. Inhaled mannitol identifies methacholine-responsive children with active asthma. Pediatr Pulmonol. 2000;29(4):291–8. doi:.https://doi.org/10.1002/(SICI)1099-0496(200004)29:4<291::AID-PPUL9>3.0.CO;2-A
  27. Kim MH, Song WJ, Kim TW, Jin HJ, Sin YS, Ye YM, et al. Diagnostic properties of the methacholine and mannitol bronchial challenge tests: a comparison study. Respirology. 2014;19(6):852–6. doi:.https://doi.org/10.1111/resp.12334
  28. Aronsson D, Tufvesson E, Bjermer L. Comparison of central and peripheral airway involvement before and during methacholine, mannitol and eucapnic hyperventilation challenges in mild asthmatics. Clin Respir J. 2011;5(1):10–8. doi:.https://doi.org/10.1111/j.1752-699X.2009.00183.x
  29. McClean MA, Htun C, King GG, Berend N, Salome CM. Cut-points for response to mannitol challenges using the forced oscillation technique. Respir Med. 2011;105(4):533–40. doi:.https://doi.org/10.1016/j.rmed.2010.10.013
  30. Stenfors N. Self-reported symptoms and bronchial hyperresponsiveness in elite cross-country skiers. Respir Med. 2010;104(11):1760–3. doi:.https://doi.org/10.1016/j.rmed.2010.07.014
  31. de Menezes MB, Ferraz E, Brannan JD, Martinez EZ, Vianna EO. The efficacy and safety of mannitol challenge in a workplace setting for assessing asthma prevalence. J Asthma. 2018;55(12):1278–85. doi:.https://doi.org/10.1080/02770903.2017.1418887
  32. White EC, de Klerk N, Hantos Z, Priston M, Hollams EM, James A, et al. Mannitol challenge testing for asthma in a community cohort of young adults. Respirology. 2017;22(4):678–83. doi:.https://doi.org/10.1111/resp.12955
  33. Cancelliere N, Bobolea I, López-Carrasco V, Barranco P, López-Serrano C, Quirce S. Comparative study of bronchial hyperresponsiveness to methacholine and mannitol in the initial diagnosis of asthma. J Investig Allergol Clin Immunol. 2013;23(5):361–2.
  34. Osthoff M, Michel F, Strupler M, Miedinger D, Taegtmeyer AB, Leuppi JD, et al. Bronchial hyperresponsiveness testing in athletes of the Swiss Paralympic team. BMC Sports Sci Med Rehabil. 2013;5(1):7. doi:.https://doi.org/10.1186/2052-1847-5-7
  35. Vakali S, Vogiatzis I, Florou A, Giavi S, Zakynthinos S, Papadopoulos NG, et al. Exercice-induced bronchoconstriction among athletes: Assessment of bronchial provocation tests. Respir Physiol Neurobiol. 2017;235:34–9. doi:.https://doi.org/10.1016/j.resp.2016.09.010
  36. Porpodis K, Domvri K, Kontakiotis T, Fouka E, Kontakioti E, Zarogoulidis K, et al. Comparison of diagnostic validity of mannitol and methacholine challenges and relationship to clinical status and airway inflammation in steroid-naïve asthmatic patients. J Asthma. 2017;54(5):520–9. doi:.https://doi.org/10.1080/02770903.2016.1238926
  37. Rutjes AWS, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PMM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005;51(8):1335–41. doi:.https://doi.org/10.1373/clinchem.2005.048595
  38. Leuppi JD. Bronchoprovocation tests in asthma: direct versus indirect challenges. Curr Opin Pulm Med. 2014;20(1):31–6. doi:.https://doi.org/10.1097/MCP.0000000000000009
  39. Anderson SD, Brannan JD. Bronchial provocation testing: the future. Curr Opin Allergy Clin Immunol. 2011;11(1):46–52. doi:.https://doi.org/10.1097/ACI.0b013e3283423183
  40. Brannan JD, Perry CP, Anderson SD. Mannitol test results in asthmatic adults receiving inhaled corticosteroids. J Allergy Clin Immunol. 2013;131(3):906–7. doi:.https://doi.org/10.1016/j.jaci.2012.08.028
  41. Katial RK, Covar RA. Bronchoprovocation testing in asthma. Immunol Allergy Clin North Am. 2012;32(3):413–31. doi:.https://doi.org/10.1016/j.iac.2012.06.002
  42. Stolz D, Anderson SD, Gysin C, Miedinger D, Surber C, Tamm M, et al. Airway reactivity to inhaled mannitol in cigarette smokers: a longitudinal study. Respir Med. 2007;101(7):1470–6. doi:.https://doi.org/10.1016/j.rmed.2007.01.008
  43. Sverrild A, Bergqvist A, Baines KJ, Porsbjerg C, Andersson CK, Thomsen SF, et al. Airway responsiveness to mannitol in asthma is associated with chymase-positive mast cells and eosinophilic airway inflammation. Clin Exp Allergy. 2016;46(2):288–97. doi:.https://doi.org/10.1111/cea.12609
  44. Leuppi JD, Salome CM, Jenkins CR, Koskela H, Brannan JD, Anderson SD, et al. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J. 2001;18(3):444–50. doi:.https://doi.org/10.1183/09031936.01.00058601
  45. Anderson WJ, Lipworth BJ. Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids. Hai. 2012;190(5):513–21. doi:.https://doi.org/10.1007/s00408-012-9396-6
  46. Wood LG, Powell H, Gibson PG. Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma. Clin Exp Allergy. 2010;40(2):232–41. doi:.https://doi.org/10.1111/j.1365-2222.2009.03371.x
  47. Stickland MK, Rowe BH, Spooner CH, Vandermeer B, Dryden DM. Accuracy of eucapnic hyperpnea or mannitol to diagnose exercise-induced bronchoconstriction: a systematic review. Ann Allergy Asthma Immunol. 2011;107(3):229–34.e8. doi:.https://doi.org/10.1016/j.anai.2011.06.013
  48. Anderson SD. Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2, Suppl):25S–30S. doi:.https://doi.org/10.1378/chest.10-0116
  49. Parkerson J, Ledford D. Mannitol as an indirect bronchoprovocation test for the 21st century. Ann Allergy Asthma Immunol. 2011;106(2):91–6. doi:.https://doi.org/10.1016/j.anai.2010.11.010

Most read articles by the same author(s)

1 2 > >>